Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term:
2011 / 06
PHARMAC documents that matched your search:
June Tender Notification; Contact: Notifications
(6 pages, 120 KB)
2011/06/30
30 June 2011 TENDER RESULTS The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2010/11 Invitation to Tender, dated 2…
Section H - effective 1 July 2011
(80 pages, 560 KB)
2011/06/29
Pharmaceutical Management Agency Section H for Hospital Pharmaceuticals Effective 1 July 2011 New Zealand Pharmaceutical Schedule Hospital Pharmaceuticals July 2011 Editors Kaye Wilson & Rebecca Bloor email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9,…
Allopurinol tab 300 mg, Symbicort Turbuhaler and Ovestin Cream; Contact: Notifications
(2 pages, 157 KB)
2011/06/28
FACSIMILE To Fax From Subject Date All New Zealand Pharmacies, IPA Pharmacy Facilitators and Wholesalers Autodial Kaye Wilson, Schedule Analyst Allopurinol tab 300 mg, Symbicort Turbuhaler, and Ovestin cream 28 June 2011 Pages 2 Dear Pharmacist and Wholesaler Allopurinol 300…
Chief Executive's letter regarding NPPA
(2 pages, 105 KB)
2011/06/27
Exceptional Circumstances scheme amendment PHARMAC has made changes to the Exceptional Circumstances Schemes, which are being streamlined with greater clarity being provided about the sorts of applications that may be successful. The scheme is being renamed as the ‘Named Patient…
Exceptional Circumstances now 'more permissive'
(2 pages, 72 KB)
2011/06/27
27 June 2011 Media release ‘More permissive’ system follows Exceptional Circumstances review PHARMAC is moving to a more permissive and streamlined system for assessing people seeking medicines that aren’t funded on the Pharmaceutical Schedule. The PHARMAC Board has approved changes…
Named Patient Pharmaceutical Assessment (NPPA) Policy
(10 pages, 116 KB)
2011/06/27
Named Patient Pharmaceutical Assessment (Exceptional Circumstances) Policy – June 2011 1. Introduction Section 48(b) of the New Zealand Public Health and Disability Act 2000 requires PHARMAC to, alongside managing the Pharmaceutical Schedule (“the Schedule”) and other functions, manage: incidental matters…
PHARMAC's responses to submitter's views
(18 pages, 1077 KB)
2011/06/27
Pharmaceutical Management Agency Review of Exceptional Circumstances Responses to Submitters’ Views June 2011 A433632 - qA17559 Introduction This Responses to Submitters’ views document provides PHARMAC’s responses to key points raised in submissions on proposed changes to the way PHARMAC assesses…
Proposal relating to haemophilia treatments; Closing Date: Closed; Contact: Andrew Davies
(4 pages, 110 KB)
2011/06/27
27 June 2011 Proposals to amend the terms of listing of haemophilia treatments in the Pharmaceutical Schedule PHARMAC is seeking feedback on three proposals to amend the listing of recombinant factor VIII, Factor IX and Factor Eight Inhibitors Bypass Agent…
Proposal to amend the listing of mometasone furoate lotion; Closing Date: Closed; Contact: Greg Williams
(1 page, 109 KB)
2011/06/27
27 June 2011 Proposal to amend the listing of mometasone furoate lotion PHARMAC is seeking feedback on a proposal to amend the listing of mometasone furoate (Elocon) Lotion in the Pharmaceutical Schedule through a provisional agreement with Merck Sharp and…
Summary of Submissions to Consultation on Proposed Changes
(53 pages, 1337 KB)
2011/06/27
Pharmaceutical Management Agency Review of Exceptional Circumstances Summary of Submissions to Consultation on Proposed Changes June 2011 Executive Summary PHARMAC issued a consultation document, Review of Exceptional Circumstances: Consultation on Proposed Changes, in January 2011. This document sought stakeholder…
